Journal
RSC ADVANCES
Volume 10, Issue 52, Pages 31377-31384Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0ra06405j
Keywords
-
Categories
Funding
- National Natural Science Foundation [81874291]
- Sichuan Science and Technology Program [2018HH0100]
- Outstanding Interdiscipline Project of West China Hospital of Sichuan University [ZYJC18024]
Ask authors/readers for more resources
beta-Lactam antibiotic resistance mediated by metallo-beta-lactamases (MBL) has threatened global public health. There are currently no available inhibitors of MBLs for clinical use. We previously reported the ruthenium-catalyzed meta-selective C-H nitration synthesis method, leading to somemeta-mercaptopropanamide substituted aryl tetrazoles as new potent MBL inhibitors. Here, we described the structure-activity relationship ofmeta- andortho-mercaptopropanamide substituted aryl tetrazoles with clinically relevant MBLs. The resulting most potent compound13ashowed IC(50)values of 0.044 mu M, 0.396 mu M and 0.71 mu M against VIM-2, NDM-1 and IMP-1 MBL, respectively. Crystallographic analysis revealed that13achelated to active site zinc ionsviathe thiol group and interacted with the catalytically important residues Asn233 and Tyr67, providing further structural information for the development of thiol based MBL inhibitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available